PL357827A1 - Zastosowanie substancji bradykardialnych w leczeniu schorzeń mięśnia sercowego związanych z hipertrofią oraz nowe połączenia leków - Google Patents

Zastosowanie substancji bradykardialnych w leczeniu schorzeń mięśnia sercowego związanych z hipertrofią oraz nowe połączenia leków

Info

Publication number
PL357827A1
PL357827A1 PL01357827A PL35782701A PL357827A1 PL 357827 A1 PL357827 A1 PL 357827A1 PL 01357827 A PL01357827 A PL 01357827A PL 35782701 A PL35782701 A PL 35782701A PL 357827 A1 PL357827 A1 PL 357827A1
Authority
PL
Poland
Prior art keywords
hypertrophy
treatment
diseases associated
myocardial diseases
medicament combinations
Prior art date
Application number
PL01357827A
Other languages
English (en)
Other versions
PL215235B1 (pl
Inventor
Jurgen Dammgen
Brian Guth
Randolph Seidler
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL357827A1 publication Critical patent/PL357827A1/pl
Publication of PL215235B1 publication Critical patent/PL215235B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL357827A 2000-04-13 2001-04-07 Kompozycja farmaceutyczna zawierajaca cylobradyne PL215235B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10018401A DE10018401A1 (de) 2000-04-13 2000-04-13 Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
PCT/EP2001/004034 WO2001078699A2 (de) 2000-04-13 2001-04-07 Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen

Publications (2)

Publication Number Publication Date
PL357827A1 true PL357827A1 (pl) 2004-07-26
PL215235B1 PL215235B1 (pl) 2013-11-29

Family

ID=7638652

Family Applications (1)

Application Number Title Priority Date Filing Date
PL357827A PL215235B1 (pl) 2000-04-13 2001-04-07 Kompozycja farmaceutyczna zawierajaca cylobradyne

Country Status (33)

Country Link
US (2) US7208508B2 (pl)
EP (2) EP1666042A3 (pl)
JP (1) JP3905386B2 (pl)
KR (1) KR20020089453A (pl)
CN (1) CN1245963C (pl)
AT (1) ATE330588T1 (pl)
AU (2) AU7048401A (pl)
BG (1) BG65816B1 (pl)
BR (1) BR0109996A (pl)
CA (2) CA2404120C (pl)
CY (1) CY1105081T1 (pl)
CZ (1) CZ300549B6 (pl)
DE (2) DE10018401A1 (pl)
DK (1) DK1276476T3 (pl)
EA (1) EA006977B1 (pl)
EE (1) EE05099B1 (pl)
ES (1) ES2266216T3 (pl)
HR (1) HRP20020815A2 (pl)
HU (1) HU228387B1 (pl)
IL (2) IL152103A0 (pl)
ME (1) MEP45908A (pl)
MX (1) MXPA02009935A (pl)
NO (1) NO330311B1 (pl)
NZ (1) NZ521934A (pl)
PL (1) PL215235B1 (pl)
PT (1) PT1276476E (pl)
RS (1) RS51478B (pl)
SI (1) SI1276476T1 (pl)
SK (1) SK286075B6 (pl)
TR (1) TR200202326T2 (pl)
UA (1) UA78679C2 (pl)
WO (1) WO2001078699A2 (pl)
ZA (1) ZA200208162B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1362590B1 (en) * 2002-07-25 2004-01-07 Boehringer Ingelheim Pharma GmbH & Co.KG Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
KR20120058618A (ko) * 2003-01-31 2012-06-07 다이이찌 산쿄 가부시키가이샤 동맥 경화 및 고혈압증의 예방 및 치료를 위한 의약
CA2613417C (en) * 2005-06-27 2011-11-29 Daiichi Sankyo Company, Limited Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
JPWO2007023775A1 (ja) * 2005-08-23 2009-02-26 アステラス製薬株式会社 心房細動治療剤
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
EP1908469A1 (en) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
EP2432452B1 (de) 2009-05-20 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Pharmazeutische telmisartan-trinklösung
FR2961105B1 (fr) 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
KR101296743B1 (ko) * 2011-02-17 2013-08-20 한국과학기술연구원 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법
WO2013024036A1 (en) 2011-08-12 2013-02-21 Boehringer Ingelheim Vetmedica Gmbh Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline
WO2014122248A1 (en) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit-of-parts
PT3648761T (pt) 2017-07-07 2024-06-05 Boehringer Ingelheim Vetmedica Gmbh Telmisartan para a profilaxia ou tratamento de hipertensão em gatos
KR20220054292A (ko) 2019-07-09 2022-05-02 베링거잉겔하임베트메디카게엠베하 개의 고혈압 치료를 위한 텔미사르탄
KR102398532B1 (ko) 2020-07-20 2022-05-13 한림대학교 산학협력단 중증 지주막하출혈 진단용 조성물
KR102331806B1 (ko) 2020-07-20 2021-12-01 한림대학교 산학협력단 중증 지주막하출혈 진단용 바이오 마커

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759125A (fr) 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3541811A1 (de) 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5175157A (en) 1985-11-27 1992-12-29 Boehringer Ingelheim Gmbh Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3736866A1 (de) 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5308853A (en) * 1991-12-20 1994-05-03 Warner-Lambert Company Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
RU2078536C1 (ru) * 1993-09-02 1997-05-10 Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией
CZ86796A3 (en) 1993-09-24 1996-10-16 Procter & Gamble Novel deoxy and on oxygen substituted sugar derivatives of aminosteroidal compounds
US5595987A (en) * 1994-07-22 1997-01-21 The Trustees Of Columbia University In The City Of New York Method of slowing ventricular arrhythmias using zatebradine
US6083991A (en) * 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
DE19741635A1 (de) 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
TR200100062T2 (tr) 1998-07-10 2001-06-21 Novartis Ag Valsartan ve kalsiyum kanalı bloklayıcısının anti-hipertensif kombinasyonu
DE10018401A1 (de) 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
CA2435526A1 (en) 2002-07-25 2004-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20040138306A1 (en) 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography

Also Published As

Publication number Publication date
PL215235B1 (pl) 2013-11-29
AU7048401A (en) 2001-10-30
CA2404120A1 (en) 2001-10-25
CA2575059A1 (en) 2001-10-25
WO2001078699A3 (de) 2002-06-20
NO20024924L (no) 2002-10-11
RS51478B (sr) 2011-04-30
EE05099B1 (et) 2008-12-15
ES2266216T3 (es) 2007-03-01
CY1105081T1 (el) 2009-11-04
HUP0300917A2 (hu) 2003-08-28
SI1276476T1 (sl) 2006-10-31
EA200201053A1 (ru) 2003-02-27
US20040014795A1 (en) 2004-01-22
JP3905386B2 (ja) 2007-04-18
BG107103A (bg) 2003-04-30
ZA200208162B (en) 2003-10-17
IL152103A (en) 2008-07-08
BR0109996A (pt) 2003-05-27
AU2001270484B2 (en) 2007-01-25
CZ20023752A3 (cs) 2003-03-12
CA2404120C (en) 2008-01-22
KR20020089453A (ko) 2002-11-29
EA006977B1 (ru) 2006-06-30
US20070155679A1 (en) 2007-07-05
EP1666042A3 (de) 2006-06-21
BG65816B1 (bg) 2010-01-29
MXPA02009935A (es) 2003-02-12
EP1666042A2 (de) 2006-06-07
HUP0300917A3 (en) 2009-04-28
HU228387B1 (en) 2013-03-28
JP2003535050A (ja) 2003-11-25
DE50110262D1 (de) 2006-08-03
CN1422153A (zh) 2003-06-04
IL152103A0 (en) 2003-07-31
HRP20020815A2 (en) 2004-12-31
CZ300549B6 (cs) 2009-06-10
CN1245963C (zh) 2006-03-22
DE10018401A1 (de) 2001-10-25
EP1276476A2 (de) 2003-01-22
TR200202326T2 (tr) 2003-03-21
SK286075B6 (sk) 2008-03-05
ATE330588T1 (de) 2006-07-15
NZ521934A (en) 2007-05-31
YU76902A (sh) 2006-05-25
US7208508B2 (en) 2007-04-24
MEP45908A (en) 2011-02-10
NO330311B1 (no) 2011-03-28
DK1276476T3 (da) 2006-08-14
NO20024924D0 (no) 2002-10-11
WO2001078699A2 (de) 2001-10-25
PT1276476E (pt) 2006-09-29
SK14582002A3 (sk) 2003-03-04
UA78679C2 (en) 2007-04-25
EE200200590A (et) 2004-04-15
EP1276476B1 (de) 2006-06-21

Similar Documents

Publication Publication Date Title
PL357827A1 (pl) Zastosowanie substancji bradykardialnych w leczeniu schorzeń mięśnia sercowego związanych z hipertrofią oraz nowe połączenia leków
IL149896A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
ZA200300788B (en) Improvements in and relating to the use of honey in dressings.
AU2001270484A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2003291609A1 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
IL160018A0 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
AU2003270350A1 (en) Isoxazoles and their use in the treatment of ischemic diseases
IL153485A0 (en) New bispidine compounds and their use in the treatment of cardiac arrhythmias
PL357906A1 (pl) Środki przeciwnadciśnieniowe i ich zastosowanie
GB0029613D0 (en) Biological materials and the use thereof in the treatment of disease
AU2001223910A1 (en) Interferon-alpha use in the treatment of ewing's family of tumors
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9906217D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
MXPA03004074A (es) Derivados de retiferol y su uso en el tratamiento de enfermedades o trastornos de la piel asociadas con fotoda°o.
AU2002345165A1 (en) The use of rhein and derivatives thereof in pain treatment